Viatris Inc. (Nasdaq: VTRS), a global healthcare company, visits the Nasdaq MarketSite in Times Square. Four years ago, the company embarked on a journey to build a unique global pharmaceutical ...

has acquired Viatris Inc’s US unit-dose packaging business, formerly known as Unit Dose Laboratories, or UDL. No financial terms were disclosed. The deal is expected to close in the first half ...

As of November 26, 2024, Viatris Inc. had a $15.6 billion market capitalization, putting it in the 86th percentile of companies in the Pharmaceuticals industry. Viatris Inc. does not have a meaningful ...

Investors cheered Viatris' Q3 2024 earnings release Thursday, bidding the stock up +13.5%. Generic pharmaceuticals have performed well and Viatris is a top idea in the space that should flourish ...

Good morning, everyone, and welcome to the Viatris Q3 2024 Earnings Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an ...

Despite operational successes, Viatris faced a significant 71% drop in GAAP net earnings due to international market pressures. Viatris delivered a mixed quarter, topping earnings expectations but ...

(RTTNews) - Viatris Inc. (VTRS) released a profit for third quarter that decreased from the same period last year but beat the Street estimates. The company's earnings came in at $94.8 million ...

CANONSBURG, Pa. (AP) — CANONSBURG, Pa. (AP) — Viatris Inc (VTRS) on Thursday reported third-quarter net income of $94.8 million. On a per-share basis, the Canonsburg, Pennsylvania-based ...

Viatris (VTRS) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.78 per share a year ago. These figures ...

Viatris is one of the largest generic drug manufacturers in the world. Generic drugs make up about 40% of the firm's sales and, along with other generics manufacturers, they continues to suffer ...